arly detection of ovarian cancer by tumor-epithelium targeted molecular ultrasound imaging in association with corresponding serum markers
نویسنده
چکیده
4641: IL-16 in association with VEGFR-2 detectearly tumor associated changes in the ovary.Aparna Yellapa1, Pincas Bitterman1, Jacques S. Abramowicz1, Janice M. Bahr2,SanjibBasu1, Sameer Sharma1, and Animesh Barua1 1Rush Univ. Medical Ctr., Chicago, IL;2University of Illinois at Urbana-Champaign, IL. Background: Ovarian cancer (OVCA) is a lethal malignancy of women with high rate of death among gynecological cancers. Due to the lack of an effective early detection test, OVCA in most cases are detected at late stage. Interleukin (IL)-16 is a cytokine involved in multiple immunopathobiological processes including inflammatory responses and production of proangiogenic cytokines. IL-16 is expressed by malignant epithelium and secreted in serum. Ovarian malignant transformation is followed by neovascularization and vascular endothelial growth factor receptor-2 (VEGFR-2) is a marker of tumor associated neovascularization (TAN). Thus, IL-16 and VEGFR-2 represent markers of OVCA at early stage may constitute an early detection test for OVCA. Objectives: The goal of this study was to determine whether IL-16 expression is associated with ovarian malignant transformation and to examine association between serum IL-16 levels and VEGFR-2 expression by TAN vessels during ovarian tumor development. Materials and methods: Normal (n =15) White Leghorn laying hens (3-4 years old) or hens with ovarian tumors (n=32) were selected by contrast enhanced transvaginal ultrasound scanning. Following serum collection, hens were euthanized, tissues were processed for routine histology, immunohistochemistry (IHC), protein and gene expression studies. Ovarian tumors were confirmed by gross morphology and microscopy. Expression of IL-16 by ovarian malignant epithelium and VEGFR-2 by ovarian TAN vessels were determined by IHC, immunoblotting and quantitative PCR. Serum IL-16 levels were determined by immunoassay. Correlation between serum IL-16 levels and frequencies of VEGFR-2 expressing microvessels were examined. Results: The intensity of IL-16 expression by normal ovarian epithelium was very weak (n=15). In contrast, the staining intensity of IL-16 by malignant epithelium increased significantly (p<0.001) in hens with early stage OVCA (n=15) and late stage OVCA (n=17). Compared with normal hens, serum levels of IL-16 were significantly higher in hens with early (n=15) and late stages (n=17) of OVCA (P< 0.0001). The expression of IL-16 protein and mRNA were stronger in malignant ovaries than normal ovaries. The population of VEGFR-2 expressing microvessels increased significantly (p<0.001) in hens with early stage OVCA than normal hens (p<0.001) and increased further in late stage OVCA. The increase in serum IL-16 was positively correlated with the population of VEGFR-2 expressing TAN vessels. Conclusion: IL-16 expression by ovarian malignant epithelium and its serum levels are associated with ovarian malignant transformation and correlated with VEGFR-2 expression. Thus IL-16 may be a useful serum marker and in combination with VEGFR-2 may detect OVCA at early stage. These findings will facilitate clinical studies to establish a noninvasive early OVCA detection test. Support: DOD Award # W81XWH-12-1-0460.Page 1 of 2Abstract 4641: IL-16 in association with VEGFR-2 detect early tumor associated changes... 10/28/2013mhtml:file://F:\IL-16-Report-2013-Abstract.mht Citation Format: Aparna Yellapa, Pincas Bitterman, Jacques S. Abramowicz, Janice M. Bahr, Sanjib Basu, Sameer Sharma, Animesh Barua. IL-16 in association with VEGFR-2 detect early tumor associated changes in the ovary. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4641. doi:10.1158/1538-7445.AM2013-4641Page 2 of 2Abstract 4641: IL-16 in association with VEGFR-2 detect early tumor associated changes... 10/28/2013mhtml:file://F:\IL-16-Report-2013-Abstract.mht
منابع مشابه
TITLE: Early Detection of Ovarian Cancer by Molecular Targeted Ultrasound Imaging Together with Serum Markers of Tumor-Associated Nuclear Change and Angiogenesis PRINCIPAL INVESTIGATOR:
Tumor-associated neoangiogenesis (TAN) is an early event in ovarian cancer (OVCA) development. Increased expression of vascular endothelial growth factor receptor 2 (VEGFR2) by TAN vessels presents a potential target for early detection by ultrasound imaging. The goal of this study was to examine the suitability of VEGFR2-targeted ultrasound imaging agents in detecting spontaneous OVCA in layin...
متن کاملInvestigating the diagnostic value of tumor markers compared to ultrasound in the diagnosis of ovarian tumors
Aims: Ovarian cancer has the worst prognosis among female genital tract malignancies, but if detected in the early stages, it is one of the most treatable malignancies. The aim of this study was to investigate the diagnostic value of tumor markers compared to ultrasound in the diagnosis of ovarian tumors. Materials and methods: In this cross-sectional-analytical study, 210 women referred to ...
متن کاملInterleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer
Limited resolution of transvaginal ultrasound (TVUS) scanning is a significant barrier to early detection of ovarian cancer (OVCA). Contrast agents have been suggested to improve the resolution of TVUS scanning. Emerging evidence suggests that expression of interleukin 16 (IL-16) by the tumor epithelium and microvessels increases in association with OVCA development and offers a potential targe...
متن کاملNanomedicine – The role of newer drug delivery technologies in cancer
Nanotechnology has slowly but steadily revolutionized the diagnosis, imaging and treatment of cancer. Detecting cancer at earliest stages, locating the tumor at different areas in the body and specific delivery of the drugs to malignant cells including surgically inaccessible tumors are the core areas of medical and pharmaceutical research across the world. In this endeavour, Nanodevices have e...
متن کاملNanomedicine – The role of newer drug delivery technologies in cancer
Nanotechnology has slowly but steadily revolutionized the diagnosis, imaging and treatment of cancer. Detecting cancer at earliest stages, locating the tumor at different areas in the body and specific delivery of the drugs to malignant cells including surgically inaccessible tumors are the core areas of medical and pharmaceutical research across the world. In this endeavour, Nanodevices have e...
متن کامل